Clinical trials
Observational Multiple Sclerosis, Chronic Progressive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 2 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis | 3 |
| Novartis Pharmaceuticals | 2 |
| State University of New York at Buffalo | 2 |
| Cedars-Sinai Medical Center | 1 |
| Duke University | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| John F. Foley, MD | 1 |
| LAPIX Therapeutics Inc. | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| ProgenaBiome | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 20 |
| Multiple Sclerosis, Relapsing-Remitting | 12 |
| Multiple Sclerosis | 10 |
| Autoimmune Diseases | 2 |
| Nervous System Diseases | 2 |
| Acne Vulgaris | 1 |
| Alzheimer Disease | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Anxiety Disorders | 1 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.